Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12276
CALL
Noodles & Co
NDLS
$106M
| $22.1K | ﹤0.01% |
+3,913
| New | +$22.2K |
|
|
UHG
12277
DELISTED
United Homes Group
UHG
| $21.8K | ﹤0.01% |
14,005
-56,390
| -80% | -$109K |
|
12278
CALL
SkinHealth Systems
SKIN
$91.4M
| $21.8K | ﹤0.01% |
15,700
-16,200
| -51% | -$23.4K |
|
|
CRE
12279
Cre8 Enterprise Ltd
CRE
$5.4M
| $21.8K | ﹤0.01% |
+7,872
| New | +$44.3K |
|
|
PVL
12280
PUT
Permianville Royalty Trust
PVL
$56.4M
| $21.8K | ﹤0.01% |
+12,100
| New | +$21.8K |
|
12281
Torrid Holdings
CURV
$264M
| $21.7K | ﹤0.01% |
22,222
-852,386
| -97% | -$1.09M |
|
12282
CALL
Loop Industries
LOOP
$35.2M
| $21.7K | ﹤0.01% |
+21,700
| New | +$28.7K |
|
|
BBBY.WS
12283
Bed Bath & Beyond Warrants
BBBY.WS
| $21.7K | ﹤0.01% |
+32,875
| New | +$31.3K |
|
|
WORX
12284
DELISTED
SCWORX CORP NEW
WORX
| $21.7K | ﹤0.01% |
7,811
-308
| -4% | -$1.23K |
|
12285
PUT
Immunic
IMUX
$191M
| $21.6K | ﹤0.01% |
4,050
-740
| -15% | -$5.42K |
|
|
STAK
12286
STAK Inc
STAK
$32.7M
| $21.6K | ﹤0.01% |
54,125
+12,511
| +30% | +$7.49K |
|
12287
HCW Biologics
HCWB
$5.75M
| $21.5K | ﹤0.01% |
+3,693
| New | +$62.8K |
|
12288
PUT
Tenaya Therapeutics
TNYA
$161M
| $21.4K | ﹤0.01% |
30,100
+18,100
| +151% | +$24.6K |
|
|
PN
12289
PN Smart Energy Ltd
PN
$98.1M
| $21.3K | ﹤0.01% |
+1,477
| New | +$21.7K |
|
12290
Expion360
XPON
$3.29M
| $21.3K | ﹤0.01% |
+2,619
| New | +$38.3K |
|
12291
Seer Inc
SEER
$122M
| $21.3K | ﹤0.01% |
11,625
-4,799
| -29% | -$9.79K |
|
12292
Tenon Medical
TNON
$3.34M
| $21.2K | ﹤0.01% |
22,271
+3,314
| +17% | +$3.81K |
|
12293
BioVie
BIVI
$13.8M
| $21.1K | ﹤0.01% |
18,150
-86,381
| -83% | -$139K |
|
|
SVC
12294
CALL
Service Properties Trust
SVC
$1.03B
| $21K | ﹤0.01% |
2,280
-1,580
| -41% | -$15.9K |
|
12295
CALL
Lineage Cell Therapeutics
LCTX
$279M
| $20.9K | ﹤0.01% |
12,500
-105,500
| -89% | -$183K |
|
|
TRIB
12296
CALL
Trinity Biotech
TRIB
$7.43M
| $20.8K | ﹤0.01% |
+877
| New | +$25.9K |
|
12297
CALL
Urban One Class D
UONEK
$26.1M
| $20.8K | ﹤0.01% |
+2,420
| New | +$17.7K |
|
|
ALPS
12298
ALPS Group Inc
ALPS
$66M
| $20.7K | ﹤0.01% |
+23,837
| New | +$24.8K |
|
12299
Maison Solutions
MSS
$1.3M
| $20.4K | ﹤0.01% |
+1,287
| New | +$38K |
|
|
LSH
12300
Lakeside Holding Ltd
LSH
$10.8M
| $20.3K | ﹤0.01% |
22,788
-10,758
| -32% | -$11.3K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.